Cargando…

Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results

INTRODUCTION: Omentin and vaspin are considered to have beneficial effects preventing the development of metabolic disorders which are common comorbidities in psoriasis. AIM: To evaluate the serum level of these adipokines in psoriatic patients and elucidate possible associations with disease activi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiluk, Paulina, Baran, Anna, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131968/ https://www.ncbi.nlm.nih.gov/pubmed/35645688 http://dx.doi.org/10.5114/ada.2021.103383

Ejemplares similares

Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2022)

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients
por: Kiluk, Paulina, et al.
Publicado: (2019)

Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2022)

Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data
por: Krahel, Julita Anna, et al.
Publicado: (2020)

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
por: Baran, Anna, et al.
Publicado: (2019)

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study
por: Baran, Anna, et al.
Publicado: (2020)

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis
por: Baran, Anna, et al.
Publicado: (2020)

Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis
por: Baran, Anna, et al.
Publicado: (2023)

The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis—Preliminary Results
por: Baran, Anna, et al.
Publicado: (2022)

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
por: Baran, Anna, et al.
Publicado: (2021)

Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

The Assessment of Risk and Predictors of Sleep Disorders in Patients with Psoriasis—A Questionnaire-Based Cross-Sectional Analysis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Effect of psoriasis activity on serum adiponectin and leptin levels
por: Baran, Anna, et al.
Publicado: (2015)

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein—Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome?
por: Krahel, Julita Anna, et al.
Publicado: (2020)

Aberrations in Lipid Expression and Metabolism in Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Psoriasis and neurodegenerative diseases—a review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Fatty Acid-Binding Proteins in Psoriasis—A Review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017)

Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)
por: Pazgan-Simon, Monika, et al.
Publicado: (2020)

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Insulin Administration Acutely Decreases Vaspin Serum Concentrations in Humans
por: Kovacs, Peter, et al.
Publicado: (2013)

Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin—A New Potential Link in the Pathogenesis of Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2019)

Kynurenine Pathway in Psoriasis—a Promising Link?
por: Stepaniuk, A., et al.
Publicado: (2023)

Maskne—Dermatosis of a Pandemic. A Survey on the Impact of PPE on Facial Skin Among HCW and N-HCW in Poland
por: Malczynska, Izabela U., et al.
Publicado: (2022)

Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
por: Kukla, Michał, et al.
Publicado: (2017)

Association of vaspin rs2236242 gene polymorphism with serum vaspin level, insulin resistance and diabetes in an Iranian diabetic/pre-diabetic population
por: Hosseini, Maria, et al.
Publicado: (2021)

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients
por: Myśliwiec, Hanna, et al.
Publicado: (2016)

The Investigation of Serum Vaspin Level in Atherosclerotic Coronary Artery Disease
por: Kobat, Mehmet Ali, et al.
Publicado: (2012)

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease
por: Cantarini, L, et al.
Publicado: (2011)

The serum vaspin levels are reduced in Japanese chronic hemodialysis patients
por: Inoue, Junko, et al.
Publicado: (2012)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022)

Vaspin in Developing Obesity (Vande-Ob); the Correlation of Waist Circumference and Visceral Fat Percentage with Vaspin Levels in Patients with Type II Diabetes Mellitus
por: Dwipayana, I Made Pande, et al.
Publicado: (2019)

Evaluation of Tissue Expression of Vaspin and Serum Vaspin Concentration as a Prognostic and Risk Factor in Endometrial Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

The adipokine vaspin reduces apoptosis in human hepatocellular carcinoma (Hep-3B) cells, associated with lower levels of NO and superoxide anion
por: Skonieczna, Magdalena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2gd5aap2gv6773q9dia6tncq4s